NCT Number: NCT02265822
Melatonin Premedication in Children Undergoing Surgery
Melatonin has been proposed as alternative to midazolam as a premedication in procedures preceding anaesthesia induction. The objective of this prospective, randomized, double-blind study is to investigate the possible effect of melatonin premedication on the required infusion of propofol in comparison to midazolam, evaluating the efficacy of oral melatonin on sedation in children undergoing surgery.
Preoperative anxiety and postoperative analgesia are also assessed in both groups.
Looking for future studies?
Notify MeKey information
Conditions
Age range
5 year–14 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
About this study
Children between the age of 5 and 14 years scheduled for elective surgery will be prospectively enrolled between September 2012 and October 2013. A physician will perform the clinical examination for each child, and anamnestic data will be collected in the medical records. Exclusion criteria will be: patients who had taken benzodiazepines, opioid drugs, or other sedative in the previous month; those who had sedation previously, or those with a temperament disorder, patients undergoing emergency surgery. Patients will be randomly assigned to 2 groups based on whether they will receive 0.2 mg/kg (max 5 mg) oral melatonin premedication (group A) or 0.5 mg/kg (max 20 mg) oral midazolam premedication (group B) before induction anaesthesia with propofol. For elective surgery, premedication will be performed between 07:30 and 09:30 h. Approximately 40 min before the induction of general anaesthesia, patients will be transported in a quiet room in the operating suite where they will receive orally melatonin or midazolam. The melatonin will be prepared by a dedicated resident in a fixed volume of 5 ml adding water in a syringe without needle. To simulate the sweet taste of the formulation of melatonin used, midazolam will be expanded to the fixed volume with 5% dextrose. The content of the syringe, in both cases marked with a coded label, will be blindly administrated to patients by the attendant nurse, not involved in the study. The child's level of sedation will be assessed and recorded by a resident before the premedication and 40 min after the administration of melatonin or midazolam, using the University of Michigan Sedation Scale (UMSS). In the operating room, an initial bolus dose of 1 mg/kg of intravenous propofol will be administered to both groups, followed by similar bolus doses of propofol until the patient will be anesthetized. Children will be considered anesthetized when asleep and not arousable. Anaesthesia will be maintained with inhalated sevoflurane. The total dose of propofol administrated will be recorded by the anaesthetist blinded to premedication group assignment. To provide objective information on the physical condition of patients after anaesthesia, Aldrete scale will be calculated after 10 min from conclusion of anaesthesia. Preoperative anxiety and postoperative analgesia will be also assessed in both groups.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Children between the age of 5 and 14 years scheduled for elective surgery
Exclusion criteria
- Patients who had taken benzodiazepines, opioid drugs, or other sedative in the previous month
- Those who had sedation previously, or those with a temperament disorder, patients undergoing emergency surgery
Treatment and study plan
midazolam in children premedication
DrugPrimary outcomes
-
efficacy of melatonin as premedicant in children undergoing elective surgery
Time frame: day 1: 40-45 min after melatonin or midazolam premedication
the required infusion of propofol required during induction of general anaesthesia in both groups will be evaluated
Secondary outcomes
-
effect of melatonin premedication in postoperative analgesia in children undergoing elective surgery
Time frame: day 1: 40 min after melatonin or midazolam premedication
The child's level of sedation will be assessed and recorded using the University of Michigan Sedation Scale (UMSS).
-
effect of melatonin premedication in postoperative analgesia in children undergoing elective surgery
Time frame: day 1: 3, 6, and 12 hours post surgery
post procedural pain will be assessed and recorded in both groups
Sponsors and collaborators
Lead sponsor
Azienda Ospedaliera Universitaria Policlinico "G. Martino"
Other
Collaborators
- Eloisa Gitto
- Gabriella D'Angelo
- Lucia Marseglia
- Pietro Impellizzeri
- Sara Manti
- Simona Montalto
Registry information
Official study title
Assessment of the Effects of Melatonin on Preoperative Anxiety and Postoperative Analgesia in Children Undergoing Surgery: a Prospective, Randomized Clinical Trial
Important dates
- Study start
- 2012
- Primary completion
- 2013
- Study completion
- 2013
- First posted
- Oct 16, 2014
- Registry last updated
- Oct 16, 2014
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
EMERGENCE AGITATION After Premedication IN PAEDIATRIC MAGNETIC RESONANCE IMAGING: A RETROSPECTIVE COHORT STUDY
NCT05946928
Autism Spectrum Disorder, Brain Diseases
Rome, Italy
View Trial DetailsIntranasal Versus Intravenous Dexmedetomidine for Hypotensive Anesthesia in FESS
NCT05604599
Agnosia, Analgesia
Damietta, Egypt
View Trial DetailsPremedication Trial for Tracheal Intubation of the NEOnate
NCT01490580
Endotracheal Intubation, Neurologic Manifestations
Amiens, France
View Trial DetailsOral Dexmedetomidine vs Midazoam For Premedication
NCT03357718
Premedication
View Trial Details